Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
BMC Cancer|August 1, 2024
Long-term evaluation of the safety of a rectal-prostate spacer, the ProSpace® balloon, in patients treated with radiotherapy for prostate cancerG Janoray, E Bruguière, J Mazurier, et al.Infection and Immunity|February 7, 1998
Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding proteinE Elass-Rochard, D Legrand, V Salmon, et al.European Journal of Biochemistry|December 17, 1984
Human lactotransferrin: amino acid sequence and structural comparisons with other transferrinsM H Metz-Boutigue, J Jollès, J Mazurier, et al.Glycoconjugate Journal|June 1, 1995
Flow cytofluorimetric analysis of young and senescent human erythrocytes probed with lectins. Evidence that sialic acids control their life spanD Bratosin, J Mazurier, H Debray, et al.Biochimie|May 20, 1998
Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A reviewD Bratosin, J Mazurier, J P Tissier, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 14, 2021
Clinical implementation of deep-learning based auto-contouring tools-Experience of three French radiotherapy centersC Robert, A Munoz, D Moreau, et al.European Journal of Cell Biology|October 1, 1994
Immunolocalization of the lactotransferrin receptor on the human T lymphoblastic cell line JurkatB Y Bi, B Leveugle, J L Liu, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 27, 2021
Automation in radiotherapy treatment planning: Examples of use in clinical practice and future trends for a complete automated workflowP Meyer, M-C Biston, C Khamphan, et al.Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 22, 1998
Molecular mechanisms of erythrophagocytosis. Characterization of the senescent erythrocytes that are phagocytized by macrophagesD Bratosin, J Mazurier, J P Tissier, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 18, 2015
[Implementing new technology in radiation oncology: The French agency for nuclear safety (ASN) report]É-F Lartigau, A Lisbona, A Isambert, et al.Pageof 8